Center for Cancer & Blood Disorders, PC

Bethesda, Maryland 20817

0 studies enrolling now · 3 studies all time

What they study most

Breast Neoplasms, Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia (CLL), Lymphoma, Non-Hodgkin

Studies at this site

• An Extension Study for Subjects Who Are Deriving Benefit With Idelalisib (GS-1101; CAL-101) Following Completion of a Prior Idelalisib Study — Stopped early
• Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer — Stopped early
• Phase II Study of Forodesine in Subjects With Chronic Lymphocytic Leukemia (CLL) — Completed